Clostridium difficile and the microbiota
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Clostridium difficile infection (CDI) is the leading health care-associated illness. Both human and animal models have demonstrated the importance of the gut microbiota's capability of providing colonization resistance against C. difficile. Risk factors for disease development include antibiotic use, which disrupts the gut microbiota, leading to the loss of colonization resistance and subsequent CDI. Identification of the specific microbes capable of restoring this function remains elusive. Future studies directed at how microbial communities influence the metabolic environment may help elucidate the role of the microbiota in disease development. These findings will improve current biotherapeutics for patients with CDI, particularly those with recurrent disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These concepts of manipulating commensal–pathogen competition for nutrients, such as iron, may also prove relevant to C. difficile infection, where faecal microbial transfer has had therapeutic success through normalization of the commensal microbiota. 149 , 176”
From The battle for iron in enteric infections (2020) · cites this paper as [176]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 3×
“Clostridium cluster XIVa (64, 76): Proteus spp.”
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota
Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., Fukuda, S., Saito, T., Narushima, S., Hase, K., et al. (2013) · Nature · doi:10.1038/nature12331 · Cited by 2,872 · cited 1×
“Various microbes have also been observed to impact subsets of T cells, such as the induction of Tregs by Clostridium species (57) and Th17 cell differentiation by segmented filamentous bacteria (58).”
BackgroundDethlefsen, L., & Relman, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000087107 · Cited by 2,421 · cited 1×
“Dethlefsen et al. found that although recovery began within weeks of ciprofloxacin cessation, the new community did not necessarily include all community members observed before antibiotic use (36).”
BackgroundDethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361 · cited 1×
“although compositional changes may be dependent on the antibiotic used as well as the underlying microbiota community of the individual (34, 35).”
BackgroundReduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277 · cited 1×
“A decreased diversity of Firmicutes and Bacteroidetes has been observed in the microbiota of IBD patients (50).”
BackgroundLoo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946 · cited 1×
“These increases in CDI burden have occurred in conjunction with the emergence of hyperendemic strains (4, 5).”
BackgroundComposition, variability, and temporal stability of the intestinal microbiota of the elderly
Claesson, M. J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., Marchesi, J. R., Falush, D., Dinan, T., Fitzgerald, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000097107 · Cited by 1,754 · cited 6×
“Using nonsequencing methods, Hopkins et al. observed that elderly patients with CDI had higher counts of Enterobacteriaceae (Proteobacteria), Enterococcus , and Lactobacillus (both Firmicutes), whereas healthy elderly patients harbored more diverse Bacteroides strains (Bacteroide-table od, fecal microbiota transplanta…”
BackgroundInfluentialThrough Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians
Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkïla, J., Monti, D., Satokari, R., Franceschi, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010667 · Cited by 1,483 · cited 1×
“The human gut microbiome undergoes extreme changes throughout life, and it is not surprising that shifts in the microbial composition have been observed in elderly people (38, 39).”
BackgroundGaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau, C., Rochet, V., Pisi, A., De Paepe, M., Brandi, G., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.020 · Cited by 1,452 · cited 1×
“Various microbes have also been observed to impact subsets of T cells, such as the induction of Tregs by Clostridium species (57) and Th17 cell differentiation by segmented filamentous bacteria (58).”
Background
Cited by
Items 201–270 of 270
Kim, E., Kim, H., Lee, M., Kim, B., Kim, B., Kim, H., Kim, D., Kang, D., Shatta, A., Kim, J. Y., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-10970-7 · Cited by 1
Santos-Santiago, J. A., Gadda, N. C., Sellers, R. S., & Tamayo, R. (2026) · Infection and Immunity · doi:10.1128/iai.00022-26 · Cited by 2
Daza, W., Dadán, S., & Carrillo, M. M. H. (2016) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.75 · Cited by 1
Speth, J. D. (2019) · Quaternary International · doi:10.1016/j.quaint.2019.07.035 · Cited by 1
Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii
Drozdov, V. N., Arefev, K. I., Serebrova, S. Y., & Ших, Е. В. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-5-104-112 · Cited by 1
Bansal, M. (2020) · Journal of the Arkansas Academy of Science · Cited by 1
Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection
Castañeda-Mogollón, D., Doolan, C., Toppings, N. B., Amarasekara, R., Tran, T.-A., & Pillai, D. R. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2021-0636-oa · Cited by 1
Journal Summary: Microbiome-Based Therapies for Recurrent Clostridioides difficile
Chauhan, A. K., & Khanna, S. (2022) · JOURNAL OF GASTROINTESTINAL INFECTIONS · doi:10.1055/s-0042-1757605 · Cited by 1
Benefits and safety of probiotics in gastrointestinal diseases
Profir, M., Roşu, O. A., Ionescu, R. F., Pavelescu, L. A., & Creţoiu, S. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824472-2.00011-7 · Cited by 5
Nosocomial Bacterial Infections: Epidemiology, Source, and Antibiotic Resistance
Hajiarab, T., Mostafavi, B., & Firoozeh, F. (2024) · International Journal of Enteric Pathogens · doi:10.34172/ijep.5640 · Cited by 1
The impact of gastric acid suppression on the developing intestinal microbiome of a childPreprint
Spurr, A., Zhu, W., Wendy, S., Diez, M. B., Ian, L., Louis‐Jacques, O., Vilboux, T., Niederhuber, J. E., Shira, L. L., & Suchitra, K. H. (2021) · medRxiv · doi:10.1101/2021.12.21.21268064 · Cited by 1
“Freedberg et al. demonstrated a change in taxa previously associated with CDI including an increase in Enterococcaceae and Streptococcaceae and a decrease in Clostridiales (23).”
BackgroundResultInfluentialCohen, S. H., Louie, T., & McGovern, B. (2023) · JAMA · doi:10.1001/jama.2023.0496 · Cited by 1
Guo, Y., Zhang, Y., Wang, G., Liu, H., Wang, J., Deng, X., He, L., & Qiu, J. (2025) · eLife · doi:10.7554/elife.101757.3 · Cited by 1
Kirupananthan, A. (2015) · Gastrointestinal Nursing · doi:10.12968/gasn.2015.13.10.48
Holma, T. (2015) · Helda - University of Helsinki Institutional Repository · Cited by 2
Systembiologie, Toxine und Epidemiologie von Clostridium difficile
Jahn, D. (2015) · BIOspektrum · doi:10.1007/s12268-015-0606-7
Mooyottu, S. (2016) · OpenCommons - UConn (University of Connecticut)
C. difficile Microbiome Manipulation
Wick, J., Basein, T., & Doron, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-60980-5_16
Fecal Transplantation Against Recurrent Clostridium difficile Infection
Abadi, A. T. B., Wren, A., Abdulkhakov, S. R., & Rizvanov, A. A. (2018) · BioNanoScience · doi:10.1007/s12668-018-0545-0
“Comprehensive Digestive Stool Analysis (CDSA) [10] and culture-independent high-density pyrosequencing [11, 13, 14].”
BackgroundBleach-It-Away Clostridium difficile
Hecker, K. I. (2018) · ScholarWorks (Walden University)
Natural Strategies for Controlling Virulence and Antibiotic Resistance in Clostridium difficile
Pellissery, A. J. (2019) · OpenCommons - UConn (University of Connecticut)
Hasan, D., & Reilly, K. (2016) · University of Western Ontario Medical Journal · doi:10.5206/uwomj.v85i1.4200
Intestinal Damage Fades, but Insults Linger: Setting the Immunological Tone for Infection
Close, L. A., & Young, V. B. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.04.008
Self-citationUtilization of Faecal Microbiota in Humans and Animals
kwang-keun, C., Kim, S.-H., Park, S.-Y., Lee, J. M., & Jo, S.-Y. (2020) · Journal of Agriculture & Life Science · doi:10.14397/jals.2020.54.1.1
Role of Gut Microbiome on Metabolic Disorders
Oshim, I. O., Agbakoba, N. R., Urama, E. U., Odeyemi, O., Olise, N. A., & John, G. U. (2020) · Journal of Advances in Medical and Pharmaceutical Sciences · doi:10.9734/jamps/2020/v22i530171
“difficile infection is a typical result of severe dysbiosis in the gut microbiome [61,62].”
BackgroundHistory of Cholecystectomy and Risk of Clostridium Difficile Infection
Jin, A., Chien, T., Huang, Q., Kenkare, P., Vu, M., Wilson, S. R., & Huang, E. S. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06714-4
Jardine, S. (2018) · TSpace (University of Toronto)
Castaño, A. M. V. (2021) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2021.13.001938
“Various studies have shown that the use of antacids and medications such as metformin could also be a risk factor [8].”
BackgroundC. difficile Microbiome Manipulation
Penney, J. A., Wick, J., Basein, T., & Doron, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-98427-4_16
HUNT FOR NON-ANTIBIOTIC ANTIBACTERIAL APPROACHES: A POSSIBLE GAME CHANGER?
(2022) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2022/11.8.6289
Akram, L., Mazumder, M. W., Begum, F., Musabbir, N., & Hassan, M. N. (2024) · Paediatrica Indonesiana · doi:10.14238/pi64.3.2024.277-80
Guo, Y., Zhang, Y., Wang, G., Liu, H., Wang, J., Deng, X., He, L., & Qiu, J. (2024) · eLife · doi:10.7554/elife.101757.1
Tavşanlarda Sindirim Sistemi Anatomisi
DOĞAN, G. K. (2024) · Bidge Yayınları eBooks · doi:10.70269/10.70269/4587649757
Guo, Y., Zhang, Y., Wang, G., Liu, H., Wang, J., Deng, X., He, L., & Qiu, J. (2025) · eLife · doi:10.7554/elife.101757.2
MICROBIOMA INTESTINAL E SUA INFLUÊNCIA NAS DOENÇAS GASTROINTESTINAIS
Portella, M. C. D. C., SOUZA, J. F. D., SANTOS, H. O. D. A. A., de Souza, L. P., & PONTES, T. D. S. M. (2025) · Editora Pasteur eBooks · doi:10.59290/978-65-6029-250-5.22
Cysteine proteases and how YabG fits into clan CD of the MEROPS database
Osborne, M. S., & Sorg, J. A. (2025) · Journal of Bacteriology · doi:10.1128/jb.00246-25
A novel ‘smart’ antibiotic may target most common bacterial infection contracted in US hospitals
Stewart, D. B., & Sharma, A. K. (2018) · The Conversation · doi:10.64628/aai.7qjtsccpu
Munoz-Price, L. S., Atkinson, S. N., Lam, V., Buchan, B. W., Ledeboer, N. A., Salzman, N. H., & Pan, A. (2025) · Microorganisms · doi:10.3390/microorganisms13102277 · Cited by 2
“Healthy people with diverse microbiota may react to initial spore exposure differently from individuals whose metabolic and microbial environment of the gut has been disturbed [2].”
Unravelling three-way interactions between Clostridioides difficile, microbiota and the host
Bywater-Brenna, K. K., & Unnikrishnan, M. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002067
“A plethora of studies looking more closely at C. difficile interactions with the resident microbiota have been conducted in recent years, and specific antibiotic-driven perturbations of the gut microbiota have been associated with CDI development, outcome and risk [2, 40].”
Park, H.-M., Lee, J., Lee, S. Y., Kim, C. H., & Kim, H. R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207190
“More-over, dysbiosis may initiate necrotizing enterocolitis in newborns [30], as well as colorectal cancer and Clostridium difficile -associated diarrhea in adults [4,31].”
Litzenburger, J. (2024) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-46078
Tan, D. T. (2022) · Mspace (University of Manitoba)
The role of surface layer proteins in clostridium difficile bacteriophage infection
Ospina-Bedoya, M. (2017) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
The impact of habitat fragmentation on bacterial interactions and community formation
Batsch, M. (2025) · IRIS
Rooney, A. M. (2022) · TSpace (University of Toronto)
Predictors of Recurrent Clostridioides difficile Infection
Todor, S. B., Boicean, A., Teodoru, M., Anderco, P., Stoia, O., Popa, M. L., & Ichim, C. (2026) · Diagnostics · doi:10.3390/diagnostics16070969 · Cited by 1
Microbial pairing alters metabolic wiring
Li, L. (2026) · Nature Ecology & Evolution · doi:10.1038/s41559-026-03045-x
Material designs for maintenance of immunological homeostasis
Yuzuriha, K. (2020) · Institutional Repositories DataBase (IRDB)
Caractérisation du biofilm de Clostridium difficile : du support inerte à la colonisation digestive
Soavelomandroso, A. P. (2017) · theses.fr (ABES) · doi:10.70675/623af393zbbf6z4acez85cdzb7359299582a
Impact du déficit en IgA sur la symbiose hôte/microbiote intestinal chez l'homme
Fadlallah, J. (2016) · theses.fr (ABES) · doi:10.70675/25fac2cezb08az46e0z8164zf88fa6d3d12a · Cited by 1
Analyse fonctionnelle des N-déacétylases de Clostridium difficile
Coullon, H. (2018) · theses.fr (ABES) · doi:10.70675/22601f10za273z4c0dzbeb2z5def29cbb1de · Cited by 2
Malet-Villemagne, J. (2022) · theses.fr (ABES) · doi:10.70675/dcdc2ad0z8b91z4774z97a2zad2f42b36f14
The role of non-coding RNAs (ncRNA) in the pathogenesis of Clostridioides difficile
Piattelli, E. (2023) · theses.fr (ABES) · doi:10.70675/430fbe25ze30az4c99z8defz8d76a374d4c5
Ngako, T. S. K. (2025) · theses.fr (ABES) · doi:10.70675/e1dad44ez06faz4daaz9dd8z5366e0263073
Understanding the human microbiome
Farooqui, A. K., Farooqui, A. K., & Amir, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40551-8.00006-8
KALVA, P. R., MARA, H., GUNNAM, P. R., Dyavannavar, P. M., & SAGAR, S. (2026) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2026v19i6.58876
“…following antibiotic exposure , reduce microbial diversity and impair colonization resistance, increasing susceptibility to intestinal disorders such as Faecalibacterium prausnitzii bacteria such as – both of which contribute to chronic inflammation and disrupt the intestinal barrier [10].”
InfluentialNon-Severe Clostridium difficile Infection
Ullah, K. I., & Aroniadis, O. C. (2026) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2026.05.005
Colobine gut microbiome vulnerability to captivity: a meta-analysis of herbivorous primates
Todó-Llorens, M., Rooney, N. J., & Peachey, L. (2026) · Animal Microbiome · doi:10.1186/s42523-026-00600-6
“FMT from healthy individuals has shown promise in restoring microbial diversity and function in other mammals [70, 71].”
Castro-Peña, C., Quesada-Gómez, C., & Chaves‐Olarte, E. (2026) · Anaerobe · doi:10.1016/j.anaerobe.2026.103074
Tian, L., Xu, S., Xie, X., Wang, M., & Huang, L. (2026) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2026.1902608
Bermúdez, A. M., Milosevic, S., Ramos-Real, M. J., SALIDO, E. C., Irribarren, J. L., Lecuona, M., López-Lirola, A. M., González‐Dávila, E., Gonzalez, B., Garcia, R., et al. (2026) · Antibiotics · doi:10.3390/antibiotics15090939
“…consumption, propensity for transmission in healthcare settings, the inefficiency of conventional cleaning methods us-ing detergents to control its spread, and elevated recurrence rates in higher-risk populations necessitate close surveillance of this pathogen in clinical facilities [5–8].”
Diego, L. D. (n.d.) · UnissResearch (Università degli Studi di Sassari)
Yoon, E.-J., Ha, N., & Jeong, M. C. (2026) · iScience · doi:10.1016/j.isci.2026.118069
Lal, D., Pandey, H., & Wong, S. H. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.125329
Metadata
- Authors
- Seekatz, A. M., & Young, V. B.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Young, Vincent B.
- Venue
- Journal of Clinical Investigation
- Published
- 2014-07-18
- Volume
- 124
- Issue
- 10
- Pages
- 4182-4189
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4191019
- OpenAlex
- W2020298266
- Cited by
- 255
- References
- 100
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 15 · 2023: 16 · 2022: 22 · 2021: 17 · 2020: 31 · 2019: 23 · 2018: 28 · 2017: 28 · 2016: 19 · 2015: 13 · 2014: 4
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Michigan (48109)
- National Institutes of Health
- College of Pharmacy, University of Michigan
- Medical School, University of Michigan
- National Institute of Allergy and Infectious Diseases (U19AI090871)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Clostridium difficile infection, gut microbiota, colonization resistance, antibiotic-induced dysbiosis, recurrent Clostridium difficile infection, biologic therapy, nosocomial infections
- MeSH terms
- Age Factors, Aged, Animals, Clostridium Infections, Humans, Immune System, Recurrence, Risk Factors, Spores, Bacterial, Clostridioides difficile, Gastrointestinal Tract, Mice, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.